HOOD vs RNA · P/E 48, rev $2.38B vs rev $22.6M
Robinhood Markets Inc (HOOD) versus Atrium Therapeutics, Inc. Common Stock (RNA) — a side-by-side from cached financials, not a winner call.
Robinhood Markets Inc (HOOD) is a capital markets company listed on NASDAQ. It is led by Vladimir Tenev.
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Latest reported HOOD revenue for 2026-06-30 was $2.38B. Net income was $911.0M. HOOD currently screens at market cap $88.36B and trailing P/E 47.6.
Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.
HOOD currently screens at market cap $88.36B and trailing P/E 47.6. RNA currently screens at market cap $217.5M.
Not investment advice. Open the HOOD and RNA stock pages for the full models.
Not investment advice.